CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
作者:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi
收藏  |  浏览/下载:22/0  |  提交时间:2022/12/23
The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer 期刊论文
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 卷号: 21
作者:  Chen, Keyu;  Wu, Jiayi;  Fang, Ziru;  Shao, Xiying;  Wang, Xiaojia
收藏  |  浏览/下载:27/0  |  提交时间:2022/12/22
Identified potential pathogenic variants of BARD1 in 1449 Chinese high-risk breast cancer patients. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Wang, Rong;  Ye, Weiwu;  Chen, Zhanhong;  Shao, Xiying;  Cao, Wenming
收藏  |  浏览/下载:8/0  |  提交时间:2022/12/23
Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Chen, Zhanhong;  Wang, Xiaojia;  Huang, Jian;  Zheng, Yabing;  Shao, Xiying
收藏  |  浏览/下载:18/0  |  提交时间:2022/12/23
BRCANet: A deep hybrid network in predicting BRCA1/2 gene mutation of breast cancer with dynamic contrast-enhanced breast MRI. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Cao, Wen-Ming;  Wang, Xiaojia;  Liu, Jian;  Wang, Lili;  Zhang, Xiaodong
收藏  |  浏览/下载:14/0  |  提交时间:2022/12/23


©版权所有 ©2017 CSpace - Powered by CSpace